Overall , telemedicine was shown to be beneficial , with home-based teletransmission effectively reducing all-cause mortality and HF-related hospital admission , length of stay and mortality in patients with HF
Telemedicine interventions may be associated with reductions in hospital admission rate and mortality in patients with heart failure ( HF ) .
Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial.
AIMS This multicentre , r and omized controlled trial hypothesized that daily electronic transmission of body weight to a heart failure ( HF ) clinic will reduce cardiac hospitalization in patients recently hospitalized with HF . METHODS AND RESULTS A total of 344 patients were r and omized to either an  intervention group ( IG ) or a control group ( CG ) . Of the 319 patients included in the final analysis , the mean age was 73 years ( SD 10.2 ) , 75 % were males , and 57 % had a left ventricular ejection fraction ( LVEF ) < 30 % . Patients in both groups were recommended to weigh themselves daily and , in the case of sudden weight gain > 2 kg in 3 days , to contact the HF clinic . Patients in the IG were given an electronic scale and the weight was automatically transmitted to and monitored at the HF clinic . No significant differences were found for the primary endpoint , cardiac re-hospitalization [ 70/153 CG , 70/166 IG ; hazard ratio ( HR ) 0.90 , 95 % confidence interval ( CI ) 0.65 - 1.26 , P = 0.54 ] , or for the secondary endpoints , which included all-cause hospitalization ( 84/153 CG , 79/166 IG ; HR 0.83 , 95 % CI 0.61 - 1.13 , P = 0.24 ) , death from any cause ( 8/153 CG , 5/166 IG ; HR 0.57 , 95 % CI 0.19 - 1.73 , P = 0.32 ) , or the composite endpoint of cardiac hospitalization and death from any cause ( 78/153 CG , 75/166 IG ; HR 0.90 , 95 % CI 0.65 - 1.26 , P = 0.54 ) . Subgroup analyses did not show any benefits for patients in the IG despite their more frequent monitoring ; 398 occasions compared with 30 occasions in the CG . CONCLUSION Daily electronic transmission of body weight and monitoring three times a week did not decrease hospitalization or death in HF patients followed up at a HF clinic
Overall , telemedicine was shown to be beneficial , with home-based teletransmission effectively reducing all-cause mortality and HF-related hospital admission , length of stay and mortality in patients with HF
Telemedicine interventions may be associated with reductions in hospital admission rate and mortality in patients with heart failure ( HF ) .